These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Valproic acid -- clinical efficiency and serum concentration in the treatment of petit mal epilepsy in childhood (author's transl)]. Fritsch G, Haidvogl M, Gleispach H, Ladurner G. Padiatr Padol; 1981; 16(4):481-8. PubMed ID: 6795573 [Abstract] [Full Text] [Related]
23. Effect of delayed and/or missed enteric-coated divalproex doses on valproic acid concentrations: simulation and dose replacement recommendations for the clinician. Dutta S, Reed RC. J Clin Pharm Ther; 2006 Aug; 31(4):321-9. PubMed ID: 16882100 [Abstract] [Full Text] [Related]
27. Anticonvulsant drug effects in the direct cortical ramp-stimulation model in rats: comparison with conventional seizure models. Krupp E, Löscher W. J Pharmacol Exp Ther; 1998 Jun; 285(3):1137-49. PubMed ID: 9618416 [Abstract] [Full Text] [Related]
28. The spectrum of the new antiepileptic drugs. Perucca E. Acta Neurol Belg; 1999 Dec; 99(4):231-8. PubMed ID: 10674140 [Abstract] [Full Text] [Related]
29. The influence of old age and enzyme inducing comedication on the pharmacokinetics of valproic acid at steady-state: A case-matched evaluation based on therapeutic drug monitoring data. Fattore C, Messina S, Battino D, Croci D, Mamoli D, Perucca E. Epilepsy Res; 2006 Aug; 70(2-3):153-60. PubMed ID: 16730950 [Abstract] [Full Text] [Related]
30. Mechanism of action of antiepileptic and antimyoclonic drugs. Pranzatelli MR, Nadi NS. Adv Neurol; 1995 Aug; 67():329-60. PubMed ID: 8848979 [Abstract] [Full Text] [Related]
31. Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part I: Phenobarbital, primidone, valproic acid, ethosuximide and mesuximide. Battino D, Estienne M, Avanzini G. Clin Pharmacokinet; 1995 Oct; 29(4):257-86. PubMed ID: 8549027 [Abstract] [Full Text] [Related]
34. Use of ethosuximide and valproate in the treatment of epilepsy. Wallace SJ. Neurol Clin; 1986 Aug; 4(3):601-16. PubMed ID: 3092003 [Abstract] [Full Text] [Related]
35. Certain aspects of interaction between sodium valproate and other anticonvulsant drugs in the therapy of epilepsy in children. Sobaniec W. Mater Med Pol; 1992 Aug; 24(2):115-9. PubMed ID: 1307765 [Abstract] [Full Text] [Related]
37. Valproate as a mainstay of therapy for pediatric epilepsy. Guerrini R. Paediatr Drugs; 2006 Aug; 8(2):113-29. PubMed ID: 16608372 [Abstract] [Full Text] [Related]
38. Practical considerations in anticonvulsant therapy--Part 2. Meyer MC, Cloyd J, Garnett WR, Holmes GL, Schiffer JR. Am Pharm; 1995 Sep; NS35(9):31-6, 40. PubMed ID: 7484814 [Abstract] [Full Text] [Related]
39. Oxcarbazepine: an update of its efficacy in the management of epilepsy. Wellington K, Goa KL. CNS Drugs; 2001 Sep; 15(2):137-63. PubMed ID: 11460891 [Abstract] [Full Text] [Related]
40. [The treatment of epilepsies with Convulsofin]. Rabending G, Beier R, Cammann R, Du Chesne HJ, Gebelt H, Grimmberger M, Hobusch D, Klepel H, König K, Knaape HH, Michalowski B, Müller D, Oettinger B, Suhr G, Todt H, Vesper J, Wendt U, Zettler H. Psychiatr Neurol Med Psychol (Leipz); 1981 Oct; 33(10):618-28. PubMed ID: 6798596 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]